Phenotypic heterogeneity in the NCI-H125 cell line affects biological activity using the epidermal growth factor receptor as target / Fenotipska heterogenost u staničnoj liniji NCI-H125 utječe na biološku aktivnost na receptore za epidermalni faktor rasta

Blanco, Rancés; Cedeño, Mercedes; González, Narjara; Rodríguez, Reynier; Sánchez, Javier; Rengifo, Enrique

doi:10.2478/v10007-012-0038-6

Abstract

We evaluated the influence of some morphological changes of the NCI-H125 cell line in surface expression of the epidermal growth factor receptor (EGFR) and their impact on some biological activity assays using this molecule as target. Hematoxylin and eosin (H/E) staining, light microscopy immunocytochemistry, flow cytometric antibody-receptor binding test, cell viability determination and cell cycle analysis were performed. Phenotypic changes and inconsistency in EGFR expression were detected in NCI-H125 cell cultures. A significant reduction in the growth rate, mainly characterized by cell cycle arrest in the G0-G1 phase, was also evidenced. Differential distribution of cell viability in NCI-H125 subpopulations and its relationship with the EGFR surface expression were determined. Nuclear alterations observed in NCI- -H125 were not apoptosis related. A lack of control of cell cultures affects the reliability and reproducibility of biomedical and biotechnological research using EGFR as target. Therefore, rigorous control of the above mentioned parameters in these experiments is recommended.

References

1. R. S. Herbst, Review of epidermal growth factor receptor biology, Int. J. Radiat. Oncol. Biol. Phys. 59 (2004) 21-26; DOI: 10.1016/j.ijrobp.2003.11.041.10.1016/j.ijrobp.2003.11.04115142631
Search in Google Scholar
2. H. Zhang, A. Berezov, Q. Wang, G. Zhang, J. Drebin, R. Murali and M. I. Greene, ErbB receptors: from oncogenes to targeted cancer therapies, J. Clin. Invest. 117 (2007) 2051-2058; DOI: 10.1172/JCI32278.10.1172/JCI32278193457917671639
Search in Google Scholar
3. A. Kendall, R. Lord and N. Maisey, Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer, Recent. Pat. Anticancer Drug Discov. 5 (2010) 142-151; DOI: 10. 2174/157489210790936270.10.2174/15748921079093627019954416
Search in Google Scholar
4. M. S. Ramakrishnan, A. Eswaraiah, T. Crombet, P. Piedra, G. Saurez, H. Iyer and A. S. Arvind, Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin, mAbs 1 (2009) 41-48; DOI: 10.4161/mabs.1.1.7509.10.4161/mabs.1.1.7509271518120046573
Search in Google Scholar
5. R. C. Chatelier, R. G. Ashcroft, C. J. Lloyd, E. C. Nice, R. H. Whitehead, W. H. Sawyer and A.W. Burgess, Binding of fluoresceinated epidermal growth factor to A431 cell sub-populations studied using a model-independent analysis of flow cytometric fluorescence data, EMBO 5 (1986) 1181-1186.10.1002/j.1460-2075.1986.tb04344.x11669253015587
Search in Google Scholar
6. N. B. S. Abid, Z. Rouis, F. Nefzi, N. Souelah and M. Aouni, Evaluation of dimethylthiazol diphenyl tetrazolium bromide and propidium iodide inclusion assays for the evaluation of cell viability by flow cytometry, J. Appl. Pharm. Sci. 2 (2012) 10-14; DOI: 10.7324/JAPS.2012.2525.10.7324/JAPS.2012.2525
Search in Google Scholar
7. A. L. Givan, Critical Aspects of Staining for Flow Cytometry, in Living Color: Protocols in Flow Cytometry and Cell Sorting (Eds. R. Diamond and S. DeMaggio), 1st ed., Springer, Berlin 2000, pp. 142-164.
Search in Google Scholar
8. W. K. Boland and G. Bebb, Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity, Expert Opin. Biol. Ther. 9 (2009) 1-8; DOI: 10.1517/14712590903110709.10.1517/1471259090311070919624281
Search in Google Scholar
9. J. M. Reichert, Antibody-based therapeutics to watch in 2011, mAbs 3 (2011) 76-99; DOI: 10.4161/mabs.3.1.13895.10.4161/mabs.3.1.13895303801421051951
Search in Google Scholar
10. R. I. Freshney, Basic Principles of Cell Culture, in Culture of Cells for Tissue Engineering (Eds. G. Vunjak-Novakovic and R. I. Freshney), John Wiley, New York 2006, pp. 11-14.10.1002/0471741817.ch1
Search in Google Scholar
11. G. Rothe, Technical Background and Methodological Principles of Flow Cytometry, in Cellular Diagnostics. Basics, Methods and Clinical Applications of Flow Cytometry (Eds. U. Sack, A. Tarnok and G. Rothe), Karger, Basel 2009, pp. 53-88; DOI: 10.1159/000209156.10.1159/000209156
Search in Google Scholar
12. G. N. Gill and C. S. Lazar, Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells, Nature 293 (1981) 305-307.10.1038/293305a06268987
Search in Google Scholar
13. L. Nikfarjam and P. Farzaneh, Prevention and detection of mycoplasma contamination in cell culture, Cell J. (Yakhteh) 13 (2012) 203-212.
Search in Google Scholar
14. T. Mammone, D. Gan and R. Foyouzi-Youssefi, Apoptotic cell death increases with senescence in normal human dermal fibroblast cultures, Cell Biol. Int. 30 (2006) 903-909; DOI: 10.1016/j.cellbi.2006.06.010.10.1016/j.cellbi.2006.06.01016904918
Search in Google Scholar
15. S. Gupta, S. R. Indelicato, V. Jethwa, T. Kawabata, M. Kelley, A. R. Mire-Sluis, S. M. Richards, B. Rup, E. Shores, S. J. Swanson and E. Wakshull, Recommendations for the design optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics, J. Immunol. Met. 321 (2007) 1-18; DOI: 10.1016/j.jim.2004.06.002.10.1016/j.jim.2004.06.00215251407
Search in Google Scholar

Phenotypic heterogeneity in the NCI-H125 cell line affects biological activity using the epidermal growth factor receptor as target / Fenotipska heterogenost u staničnoj liniji NCI-H125 utječe na biološku aktivnost na receptore za epidermalni faktor rasta

Abstract

Paradigm

My account